71 related articles for article (PubMed ID: 25604748)
1. MicroRNA-19a functions as an oncogenic microRNA in non-small cell lung cancer by targeting the suppressor of cytokine signaling 1 and mediating STAT3 activation.
Wang X; Chen Z
Int J Mol Med; 2015 Mar; 35(3):839-46. PubMed ID: 25604748
[TBL] [Abstract][Full Text] [Related]
2. Integrin αVβ1-activated PYK2 promotes the progression of non-small-cell lung cancer via the STAT3-VGF axis.
Wu Z; Jiao M; Shu C; Zhang S; Wang J; Pu J; Zhu J; Zeng Y; Zhu Y; Liu Z
Cell Commun Signal; 2024 Jun; 22(1):313. PubMed ID: 38844957
[TBL] [Abstract][Full Text] [Related]
3. miR-342-3p Regulates the Proliferation and Apoptosis of NSCLC Cells by Targeting
Chen Z; Ying J; Shang W; Ding D; Guo M; Wang H
Technol Cancer Res Treat; 2021; 20():15330338211041193. PubMed ID: 34520298
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-181a-5p Impedes IL-17-Induced Nonsmall Cell Lung Cancer Proliferation and Migration through Targeting VCAM-1.
Cao Y; Zhao D; Li P; Wang L; Qiao B; Qin X; Li L; Wang Y
Cell Physiol Biochem; 2017; 42(1):346-356. PubMed ID: 28535543
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-506 has a suppressive effect on the tumorigenesis of nonsmall-cell lung cancer by regulating tubby-like protein 3.
Li ZH; Zhou JH; Chen SN; Pan L; Feng Y; Luo MQ; Li RX; Sun GL
Bioengineered; 2021 Dec; 12(2):10176-10186. PubMed ID: 34874810
[TBL] [Abstract][Full Text] [Related]
6. SPAG6 and L1TD1 are transcriptionally regulated by DNA methylation in non-small cell lung cancers.
Altenberger C; Heller G; Ziegler B; Tomasich E; Marhold M; Topakian T; Müllauer L; Heffeter P; Lang G; End-Pfützenreuter A; Döme B; Arns BM; Klepetko W; Zielinski CC; Zöchbauer-Müller S
Mol Cancer; 2017 Jan; 16(1):1. PubMed ID: 28093071
[TBL] [Abstract][Full Text] [Related]
7. RNA‑binding protein quaking 5 inhibits the progression of non‑small cell lung cancer by upregulating netrin‑4 expression.
Wu Z; Liu S; Pang G; Jiang H
Oncol Rep; 2023 Nov; 50(5):. PubMed ID: 37800632
[TBL] [Abstract][Full Text] [Related]
8. STAT3 Cyclic Decoy Demonstrates Robust Antitumor Effects in Non-Small Cell Lung Cancer.
Njatcha C; Farooqui M; Kornberg A; Johnson DE; Grandis JR; Siegfried JM
Mol Cancer Ther; 2018 Sep; 17(9):1917-1926. PubMed ID: 29891486
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic miR-19a and miR-19b co-regulate tumor suppressor MTUS1 to promote cell proliferation and migration in lung cancer.
Gu Y; Liu S; Zhang X; Chen G; Liang H; Yu M; Liao Z; Zhou Y; Zhang CY; Wang T; Wang C; Zhang J; Chen X
Protein Cell; 2017 Jun; 8(6):455-466. PubMed ID: 28364280
[TBL] [Abstract][Full Text] [Related]
10. Abrogation of STAT3 activation cascade by Ginkgolide C mitigates tumourigenesis in lung cancer preclinical model.
Yang MH; Ha IJ; Lee SG; Um JY; Ahn KS
J Pharm Pharmacol; 2021 Dec; 73(12):1630-1642. PubMed ID: 34559878
[TBL] [Abstract][Full Text] [Related]
11. Hypoxic Lung-Cancer-Derived Extracellular Vesicle MicroRNA-103a Increases the Oncogenic Effects of Macrophages by Targeting PTEN.
Hsu YL; Hung JY; Chang WA; Jian SF; Lin YS; Pan YC; Wu CY; Kuo PL
Mol Ther; 2018 Feb; 26(2):568-581. PubMed ID: 29292163
[TBL] [Abstract][Full Text] [Related]
12. Carcinogenic metalloid arsenic induces expression of mdig oncogene through JNK and STAT3 activation.
Sun J; Yu M; Lu Y; Thakur C; Chen B; Qiu P; Zhao H; Chen F
Cancer Lett; 2014 May; 346(2):257-63. PubMed ID: 24434654
[TBL] [Abstract][Full Text] [Related]
13. ASCC3 promotes the immunosuppression and progression of non-small cell lung cancer by impairing the type I interferon response via CAND1-mediated ubiquitination inhibition of STAT3.
Ao YQ; Gao J; Jin C; Wang S; Zhang LC; Deng J; Chen ZW; Wang HK; Jiang JH; Ding JY
J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38148115
[TBL] [Abstract][Full Text] [Related]
14. IKBKE is induced by STAT3 and tobacco carcinogen and determines chemosensitivity in non-small cell lung cancer.
Guo J; Kim D; Gao J; Kurtyka C; Chen H; Yu C; Wu D; Mittal A; Beg AA; Chellappan SP; Haura EB; Cheng JQ
Oncogene; 2013 Jan; 32(2):151-9. PubMed ID: 22330135
[TBL] [Abstract][Full Text] [Related]
15. Gene expression analysis of SOCS, STAT and PIAS genes in lung cancer patients.
Abolghasemi S; Bikhof Torbati M; Pakzad P; Ghafouri-Fard S
Pathol Res Pract; 2023 Sep; 249():154760. PubMed ID: 37586215
[TBL] [Abstract][Full Text] [Related]
16. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene.
Lee YS; Dutta A
Genes Dev; 2007 May; 21(9):1025-30. PubMed ID: 17437991
[TBL] [Abstract][Full Text] [Related]
17. IL-17 induces NSCLC cell migration and invasion by elevating MMP19 gene transcription and expression through the interaction of p300-dependent STAT3-K631 acetylation and its Y705-phosphorylation.
Ge W; Li YA; Ruan Y; Wu N; Ma P; Xu T; Shu Y; Wang Y; Qiu W; Zhao C
Oncol Res; 2024; 32(4):625-641. PubMed ID: 38560562
[TBL] [Abstract][Full Text] [Related]
18. PRMT5-mediated methylation of STAT3 is required for lung cancer stem cell maintenance and tumour growth.
Abe Y; Sano T; Otsuka N; Ogawa M; Tanaka N
Commun Biol; 2024 May; 7(1):593. PubMed ID: 38760429
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy with SOCS1 for gastric cancer induces G2/M arrest and has an antitumour effect on peritoneal carcinomatosis.
Natatsuka R; Takahashi T; Serada S; Fujimoto M; Ookawara T; Nishida T; Hara H; Nishigaki T; Harada E; Murakami T; Miyazaki Y; Makino T; Kurokawa Y; Yamasaki M; Miyata H; Nakajima K; Takiguchi S; Kishimoto T; Mori M; Doki Y; Naka T
Br J Cancer; 2015 Jul; 113(3):433-42. PubMed ID: 26180928
[TBL] [Abstract][Full Text] [Related]
20. A redox-responsive nanosystem to suppress chemoresistant lung cancer through targeting STAT3.
Feng Q; Chen J; Huang J; Li X; Liu X; Xiao C; Zheng X; Chen X; Li J; Gu Z; Luo K; Xiao K; Li W
J Control Release; 2023 Nov; 363():349-360. PubMed ID: 37748583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
